The influence of dehydroepiandrosterone on effector functions of neutrophils

• Autor(a) principal: Soares Brauer, Verônica
• Data de Publicação: 2022
• Outros Autores: Albani Zambuzi, Fabiana, Sobral Espíndola, Milena, Pacífico Cavalcanti Neto, Marinaldo, Kelly Borges Prado, Morgana, Cardoso, Priscilla Mariane, Silva Soares, Luana, Judson Galvao-Lima, Leonardo, Machado Leopoldino, Andréia, Ribeiro de Barros Cardoso, Cristina, Gai Frantz, Fabiani
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Brazilian Journal of Pharmaceutical Sciences
• Texto Completo: https://www.revistas.usp.br/bjps/article/view/204127
• topic: Dehydroepiandrosterone; Neuroimmunoendocrinology; S. typhimurium; Innate immunity; Phagocytosis

Dehydroepiandrosterone (DHEA) is a steroid hormone secreted by the adrenal glands, gonads and brain. It is a precursor to sex hormones and also is known to have immune modulatory activity. However, little is known about the relationship between DHEA and neutrophils and thus our study evaluates the influence of DHEA in the effector functions of neutrophils. Human neutrophils were treated in vitro with DHEA and further infected with Salmonella enterica serovar Typhimurium. The treatment of neutrophils with 0.01 μM of DHEA increased the phagocytosis of Salmonella independent of TLR4 as the treatment did not modulate the TLR4 expression. Additionally, DHEA caused a decrease in ROS (reactive oxygen species) production and did not influence the formation of the neutrophil extracellular trap (NET). Steroid treated neutrophils, infected or stimulated with LPS (lipopolysaccharide), showed reduced production of IL-8, compared to untreated cells. Also, the protein levels of p-NFκB were decreased in neutrophils treated with DHEA, and this reduction could explain the reduced levels of IL-8. These results led us to conclude that the steroid hormone DHEA has important modulatory functions in neutrophils.